Zurück zu Projekte

10278.1;9 PFDP-LS

Synthetic Virus-Like Particles (SVLPs): A new Approach to Synthetic Vaccines and Nanomedicine

Zusammenfassung

Synthetic Virus-Like Particles (SVLPs): A new Approach to Synthetic Vaccines and Nanomedicine

Weitere Texte

Abstract

This Discovery grant should support the launch of the start-up (spin-out) company Virometix AG. The company will exploit a fundamentally new approach for the rational design and production of immuno-therapeutic drugs and vaccines using the tools of chemistry. The so-called SVLP technology provides a breakthrough in the creation of nanoscale biological assemblies for multivalent display of epitope mimetics. A new generation of synthetic vaccines will be developed using this technology to combat infectious and chronic human diseases. The technology is based on the use of virus-like particles made using artificial, fully synthetic building blocks, to deliver target antigens to cells in the immune system.

Beteiligte

John A. Robinson

Kontaktperson

robinson@oci.uzh.ch

Universität Zürich Organisch-chemisches Institut John A. Robinson Winterthurerstr. 190 8057 Zürich ZH CH

Projektdetails

Forschungsstelle
INNOSUISSE
Projektstatus
Abgeschlossen
Projekttyp
Forschungsprojekt
Startdatum
2009-09-30
Enddatum
2012-03-13
Bewilligte Gesamtkosten
CHF 754372.00
Sektion
19 Förderbereich GL
NABS Politikbereich
Nicht aufteilbare / nicht zuteilbare Forschung

Forschungsdisziplinen

  • T490 Biotechnology 100.0%